Published in Neurosci Lett on October 18, 2007
The lighter side of BDNF. Am J Physiol Regul Integr Comp Physiol (2011) 1.38
Cellular and molecular mechanisms of immunomodulation in the brain through environmental enrichment. Front Cell Neurosci (2014) 0.87
A hypothesis on the biological origins and social evolution of music and dance. Front Neurosci (2015) 0.83
Auditory stimulation of opera music induced prolongation of murine cardiac allograft survival and maintained generation of regulatory CD4+CD25+ cells. J Cardiothorac Surg (2012) 0.82
The effect of listening to music on human transcriptome. PeerJ (2015) 0.80
From Cerebellar Activation and Connectivity to Cognition: A Review of the Quadrato Motor Training. Biomed Res Int (2015) 0.78
On the role of auditory feedback in robot-assisted movement training after stroke: review of the literature. Comput Intell Neurosci (2013) 0.78
New framework for rehabilitation - fusion of cognitive and physical rehabilitation: the hope for dancing. Front Psychol (2015) 0.78
Creating Well-Being: Increased Creativity and proNGF Decrease following Quadrato Motor Training. Biomed Res Int (2015) 0.77
Upregulation of Vanilloid Receptor-1 in Functional Dyspepsia With or Without Helicobacter pylori Infection. Medicine (Baltimore) (2016) 0.77
Emotional perception of music in children with unilateral cochlear implants. Iran J Otorhinolaryngol (2014) 0.75
Creative music therapy to promote brain structure, function, and neurobehavioral outcomes in preterm infants: a randomized controlled pilot trial protocol. Pilot Feasibility Stud (2017) 0.75
Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial. Lancet Neurol (2011) 2.44
Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain (2003) 2.11
Clinical-neurophysiological correlations in a series of patients with IgM-related neuropathy. Clin Neurophysiol (2013) 2.03
Nerve ultrasound findings in two cases of spinal accessory nerve palsy. Muscle Nerve (2014) 2.00
Sudden stopping in patients with cerebellar ataxia. Cerebellum (2013) 1.97
Gene expression profiling in the early phases of DMD: a constant molecular signature characterizes DMD muscle from early postnatal life throughout disease progression. FASEB J (2007) 1.92
Large-scale population analysis challenges the current criteria for the molecular diagnosis of fascioscapulohumeral muscular dystrophy. Am J Hum Genet (2012) 1.88
Muscle magnetic resonance imaging involvement in muscular dystrophies with rigidity of the spine. Ann Neurol (2010) 1.80
Mutations affecting the cytoplasmic functions of the co-chaperone DNAJB6 cause limb-girdle muscular dystrophy. Nat Genet (2012) 1.75
Ultrasound tissue characterization detects preclinical myocardial structural changes in children affected by Duchenne muscular dystrophy. J Am Coll Cardiol (2003) 1.72
Abnormal cortical pain processing in patients with cardiac syndrome X. Eur Heart J (2005) 1.60
Ultrasound as the first choice for peripheral nerve imaging? Neurology (2013) 1.57
Variable hypomethylation of D4Z4 in facioscapulohumeral muscular dystrophy. Ann Neurol (2005) 1.46
A dynamic ultrasonographic evaluation of the palmaris anomalous muscle. Clin Anat (2010) 1.40
Polymorphism of CAG motif of SK3 gene is associated with acute oxaliplatin neurotoxicity. Cancer Chemother Pharmacol (2010) 1.39
Chimeric snRNA molecules carrying antisense sequences against the splice junctions of exon 51 of the dystrophin pre-mRNA induce exon skipping and restoration of a dystrophin synthesis in Delta 48-50 DMD cells. Proc Natl Acad Sci U S A (2002) 1.24
Carpal tunnel syndrome modifies sensory hand cortical somatotopy: a MEG study. Hum Brain Mapp (2002) 1.19
Dystrophin quantification and clinical correlations in Becker muscular dystrophy: implications for clinical trials. Brain (2011) 1.17
CD8(+) T cells in facioscapulohumeral muscular dystrophy patients with inflammatory features at muscle MRI. J Clin Immunol (2010) 1.16
Muscular dystrophy with marked Dysferlin deficiency is consistently caused by primary dysferlin gene mutations. Eur J Hum Genet (2011) 1.16
Multi-center assessment of the Total Neuropathy Score for chemotherapy-induced peripheral neurotoxicity. J Peripher Nerv Syst (2006) 1.15
pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity. J Neurosci Res (2006) 1.15
A standardized clinical evaluation of patients affected by facioscapulohumeral muscular dystrophy: The FSHD clinical score. Muscle Nerve (2010) 1.15
Novel GNE mutations in Italian families with autosomal recessive hereditary inclusion-body myopathy. Hum Mutat (2004) 1.14
Treatment for ulnar neuropathy at the elbow. Cochrane Database Syst Rev (2012) 1.14
MyoD expression restores defective myogenic differentiation of human mesoangioblasts from inclusion-body myositis muscle. Proc Natl Acad Sci U S A (2006) 1.11
Comment on: "Ulnar Tunnel Syndrome with Ultrasonographic Nerve Imaging". Pain Physician (2015) 1.08
Leptin as a marker of multiple sclerosis activity in patients treated with interferon-beta. J Neuroimmunol (2003) 1.06
Large scale genotype-phenotype analyses indicate that novel prognostic tools are required for families with facioscapulohumeral muscular dystrophy. Brain (2013) 1.05
Unmasking of presynaptic and postsynaptic high-frequency oscillations in epidural cervical somatosensory evoked potentials during voluntary movement. Clin Neurophysiol (2007) 1.03
New phenotype and pathology features in MYH7-related distal myopathy. Neuromuscul Disord (2012) 1.03
Focal muscle vibration in the treatment of upper limb spasticity: a pilot randomized controlled trial in patients with chronic stroke. Arch Phys Med Rehabil (2012) 1.02
Isolation and characterization of mesoangioblasts from facioscapulohumeral muscular dystrophy muscle biopsies. Stem Cells (2007) 1.02
Multicenter study of peroneal mononeuropathy: clinical, neurophysiologic, and quality of life assessment. J Peripher Nerv Syst (2005) 1.01
IL17 and IFNgamma production by peripheral blood mononuclear cells from clinically isolated syndrome to secondary progressive multiple sclerosis. Cytokine (2008) 1.01
Different molecular signatures in magnetic resonance imaging-staged facioscapulohumeral muscular dystrophy muscles. PLoS One (2012) 1.00
Muscle MRI findings in patients with limb girdle muscular dystrophy with calpain 3 deficiency (LGMD2A) and early contractures. Neuromuscul Disord (2004) 0.99
A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): the study protocol [EudraCT no.: 2006-000032-27]. Pharmacol Res (2006) 0.99
Treatment for ulnar neuropathy at the elbow. Cochrane Database Syst Rev (2011) 0.98
Spectrum of brain changes in patients with congenital muscular dystrophy and FKRP gene mutations. Arch Neurol (2006) 0.98
Cardiac features of Emery-Dreifuss muscular dystrophy caused by lamin A/C gene mutations. Eur Heart J (2003) 0.98
Everything you always wanted to know about nerve, but were afraid to ask. Clin Neurophysiol (2012) 0.97
Analysis of blink rate in patients with blepharospasm. Mov Disord (2006) 0.97
Carpal tunnel syndrome in elderly patients: results of surgical decompression. J Peripher Nerv Syst (2004) 0.96
The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis. J Neuroimmunol (2007) 0.96
US imaging of the musculocutaneous nerve. Skeletal Radiol (2010) 0.95
Neurotrophic factors in relapsing remitting and secondary progressive multiple sclerosis patients during interferon beta therapy. Clin Immunol (2005) 0.95
Bilateral hand/wrist heat and cold hyperalgesia, but not hypoesthesia, in unilateral carpal tunnel syndrome. Exp Brain Res (2009) 0.95
Quality of life and pain in patients with facioscapulohumeral muscular dystrophy. Muscle Nerve (2009) 0.94
Brachial plexus and nerves about the shoulder. Semin Musculoskelet Radiol (2010) 0.94
Outcome measures and rehabilitation treatment in patients affected by Charcot-Marie-Tooth neuropathy: a pilot study. Am J Phys Med Rehabil (2011) 0.94
Diagnosis and therapy of myasthenia gravis with antibodies to muscle-specific kinase. Autoimmun Rev (2013) 0.93
Physicians' knowledge of health-related quality of life and perception of its importance in daily clinical practice. Health Qual Life Outcomes (2010) 0.93
Hyposialylation of neprilysin possibly affects its expression and enzymatic activity in hereditary inclusion-body myopathy muscle. J Neurochem (2007) 0.93
Substrate reduction therapy with miglustat in chronic GM2 gangliosidosis type Sandhoff: results of a 3-year follow-up. J Inherit Metab Dis (2010) 0.93
Ehlers-Danlos syndrome hypermobility type and the excess of affected females: possible mechanisms and perspectives. Am J Med Genet A (2010) 0.93
High-resolution sonography of the palmar cutaneous branch of the median nerve. AJR Am J Roentgenol (2008) 0.92
The Facioscapulohumeral muscular dystrophy region on 4qter and the homologous locus on 10qter evolved independently under different evolutionary pressure. BMC Med Genet (2007) 0.92
Sonographic features in hereditary neuropathy with liability to pressure palsies. Muscle Nerve (2012) 0.92
Median nerve ultrasonography in carpal tunnel syndrome: findings from two laboratories. Muscle Nerve (2009) 0.91
Reliability of side-to-side ultrasound cross-sectional area measurements of lower extremity nerves in healthy subjects. Muscle Nerve (2012) 0.91
Neprilysin participates in skeletal muscle regeneration and is accumulated in abnormal muscle fibres of inclusion body myositis. J Neurochem (2006) 0.91
Occupational exposure to antineoplastic agents induces a high level of chromosome damage. Lack of an effect of GST polymorphisms. Toxicol Appl Pharmacol (2007) 0.90
Alternative splicing alterations of Ca2+ handling genes are associated with Ca2+ signal dysregulation in myotonic dystrophy type 1 (DM1) and type 2 (DM2) myotubes. Neuropathol Appl Neurobiol (2014) 0.90
Increased CD4+CD25+Foxp3+ T cells in peripheral blood of celiac disease patients: correlation with dietary treatment. Hum Immunol (2009) 0.90
Mechanisms of neuropathic pain in patients with Charcot-Marie-Tooth 1 A: a laser-evoked potential study. Pain (2010) 0.90
Frequent low penetrance mutations in the Lamin A/C gene, causing Emery Dreifuss muscular dystrophy. Neuromuscul Disord (2002) 0.90
Outcome of surgical release among diabetics with carpal tunnel syndrome. Arch Phys Med Rehabil (2004) 0.90
Muscle imaging findings in GNE myopathy. J Neurol (2012) 0.90
Prevalence of bifid median nerve at wrist assessed through ultrasound. Neurol Sci (2011) 0.89
Investigating the neurobiology of music: brain-derived neurotrophic factor modulation in the hippocampus of young adult mice. Behav Pharmacol (2007) 0.89
Single-nucleotide polymorphisms in BER and HRR genes, XRCC1 haplotypes and breast cancer risk in Caucasian women. J Cancer Res Clin Oncol (2010) 0.89
Nerve ultrasound follow-up in a child with Guillain-Barré syndrome. Muscle Nerve (2012) 0.89
Sleep disordered breathing in facioscapulohumeral muscular dystrophy. J Neurol Sci (2009) 0.89
Gait pattern in inherited cerebellar ataxias. Cerebellum (2012) 0.88
Leptin enhances the release of cytokines by peripheral blood mononuclear cells from relapsing multiple sclerosis patients. J Clin Immunol (2004) 0.88
Intracapsular osteochondroma of the humeral head in an adult causing restriction of motion: a case report. J Shoulder Elbow Surg (2009) 0.88
pSTAT1, pSTAT3, and T-bet as markers of disease activity in chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst (2009) 0.88
Ultrasound of Focal Neuropathies. J Clin Neurophysiol (2016) 0.88
alpha-Dystroglycan does not play a major pathogenic role in autosomal recessive hereditary inclusion-body myopathy. Neuromuscul Disord (2004) 0.87
Four-week trunk-specific rehabilitation treatment improves lateral trunk flexion in Parkinson's disease. Mov Disord (2010) 0.87
Muscle MRI in Becker muscular dystrophy. Neuromuscul Disord (2012) 0.86
Molecular biomonitoring of a population of nurses handling antineoplastic drugs. Mutat Res (2007) 0.86
Mitochondrial network genes in the skeletal muscle of amyotrophic lateral sclerosis patients. PLoS One (2013) 0.86
Glucocorticoid treatment reduces T-bet and pSTAT1 expression in mononuclear cells from relapsing remitting multiple sclerosis patients. Clin Immunol (2007) 0.86
US diagnosis of sciatic nerve tumor proximal to gluteal fold. Neurol Sci (2014) 0.86
Health-related quality of life and subjective outcome after shoulder replacement for proximal humeral fractures. J Shoulder Elbow Surg (2008) 0.85
Sleep quality in Facioscapulohumeral muscular dystrophy. J Neurol Sci (2007) 0.85
Pilot trial of simvastatin in the treatment of sporadic inclusion-body myositis. Neurol Sci (2011) 0.85
Feeding problems and weight gain in Duchenne muscular dystrophy. Eur J Paediatr Neurol (2006) 0.85
Novel FLNC mutation in a patient with myofibrillar myopathy in combination with late-onset cerebellar ataxia. Muscle Nerve (2012) 0.84